These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29952488)

  • 1. [In process].
    Christ MM
    Med Monatsschr Pharm; 2017 Mar; 40(3):132-3. PubMed ID: 29952488
    [No Abstract]   [Full Text] [Related]  

  • 2. Stratified medicine and primary biliary cholangitis.
    Mells GF; Jones DE
    Lancet Gastroenterol Hepatol; 2017 May; 2(5):319-321. PubMed ID: 28397694
    [No Abstract]   [Full Text] [Related]  

  • 3. In Search of the Best Second-Line Therapy for Primary Biliary Cholangitis.
    Lens S
    Gastroenterology; 2024 Aug; 167(3):623-624. PubMed ID: 38387599
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrates for Primary Biliary Cholangitis: What's All the Hype?
    Levy C
    Ann Hepatol; 2017; 16(5):704-706. PubMed ID: 28809729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of Jaundice Following Simultaneous Ursodeoxycholic Acid Cessation and Obeticholic Acid Initiation.
    Quigley G; Al Ani M; Nadir A
    Dig Dis Sci; 2018 Feb; 63(2):529-532. PubMed ID: 29305737
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel Treatment Strategies for Primary Biliary Cholangitis.
    Parés A
    Semin Liver Dis; 2017 Feb; 37(1):60-72. PubMed ID: 28201850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New treatment options for primary biliary cholangitis].
    Keitel-Anselmino V; Nitschmann S
    Inn Med (Heidelb); 2024 Sep; 65(9):962-964. PubMed ID: 39167191
    [No Abstract]   [Full Text] [Related]  

  • 8. Specific considerations for the management of primary biliary cholangitis: are the drug treatment options good enough?
    Wetten A; Jones DEJ; Dyson JK
    Expert Opin Pharmacother; 2021 Oct; 22(15):1949-1953. PubMed ID: 34121570
    [No Abstract]   [Full Text] [Related]  

  • 9. [New name and new treatments for primary biliary cholangitits].
    Bossen L; Ytting H; Jepsen P; Hamberg O; Ott P; Grønbæk H
    Ugeskr Laeger; 2018 Mar; 180(10):. PubMed ID: 29536837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk stratification and treatment of primary biliary cholangitis.
    Martínez J; Aguilera L; Albillos A
    Rev Esp Enferm Dig; 2019 Jan; 111(1):63-70. PubMed ID: 30338693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Biliary Cholangitis: advances in management and treatment of the disease.
    Invernizzi P; Floreani A; Carbone M; Marzioni M; Craxi A; Muratori L; Vespasiani Gentilucci U; Gardini I; Gasbarrini A; Kruger P; Mennini FS; Ronco V; Lanati E; Canonico PL; Alvaro D
    Dig Liver Dis; 2017 Aug; 49(8):841-846. PubMed ID: 28546061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Treatment Options for Primary Biliary Cholangitis.
    Wong KA; Bahar R; Liu CH; Bowlus CL
    Clin Liver Dis; 2018 Aug; 22(3):481-500. PubMed ID: 30259848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of autoimmune cholangitis.
    Mohr L; Heintges T; Hensel F; Niederau C; Häussinger D
    Dig Dis Sci; 1998 Sep; 43(9):2160-3. PubMed ID: 9753287
    [No Abstract]   [Full Text] [Related]  

  • 14. Finding the cure for primary biliary cholangitis - Still waiting.
    Tanaka A; Gershwin ME
    Liver Int; 2017 Apr; 37(4):500-502. PubMed ID: 28371099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of primary biliary cholangitis ursodeoxycholic acid non-responders: A systematic review.
    Suraweera D; Rahal H; Jimenez M; Viramontes M; Choi G; Saab S
    Liver Int; 2017 Dec; 37(12):1877-1886. PubMed ID: 28517369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Old and new treatments for primary biliary cholangitis.
    Chascsa D; Carey EJ; Lindor KD
    Liver Int; 2017 Apr; 37(4):490-499. PubMed ID: 28371104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FXR Agonists: From Bench to Bedside, a Guide for Clinicians.
    Alawad AS; Levy C
    Dig Dis Sci; 2016 Dec; 61(12):3395-3404. PubMed ID: 27734248
    [No Abstract]   [Full Text] [Related]  

  • 18. Investigational drugs in phase II clinical trials for primary biliary cholangitis.
    Silveira MG; Lindor KD
    Expert Opin Investig Drugs; 2017 Oct; 26(10):1115-1121. PubMed ID: 28836457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic advances for primary biliary cholangitis: the old and the new.
    Wang L; Zhang FC; Zhang X
    Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):615-21. PubMed ID: 26862931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary biliary cholangitis: a comprehensive overview.
    Lleo A; Marzorati S; Anaya JM; Gershwin ME
    Hepatol Int; 2017 Nov; 11(6):485-499. PubMed ID: 29164395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.